Literature DB >> 16024234

Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002).

A Marchese1, L Gualco, I Cochetti, M P Montanari, A M Speciale, S R Musumeci, P E Varaldo, G Nicoletti, G C Schito.   

Abstract

During 2000-2002, 20 clinical microbiology centres collected 1623 Streptococcus pneumoniae isolates. Susceptibility to penicillin, amoxicillin, amoxicillin/clavulanic acid, cefaclor, cefuroxime, cefotaxime, clarithromycin, ciprofloxacin, levofloxacin, rifampicin and teicoplanin was determined locally by the Etest and/or by the microdilution method by three co-ordinating centres. Total resistance to penicillin increased from 15.2% to 16.1% and macrolide resistance increased from 37.9% to 43.7%. Overall, the most effective drugs (>99% susceptible strains) were amoxicillin, amoxicillin/clavulanic acid, levofloxacin and rifampicin. The most frequent serotypes were: 23F (15.8%), 3 (10.8%) 14 (9.1%), 19F (9.1%), 6B (7.2%), 19A (6.9%) and 6A (4.8%). In conclusion, penicillin and macrolide resistance is increasing in Italy, whilst fluoroquinolone currently remains active. The most common serotypes circulating are included in the heptavalent conjugate vaccine, with the exception of type 3.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024234     DOI: 10.1016/j.ijantimicag.2005.04.006

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  7 in total

1.  Streptococcus pneumoniae transposon Tn1545/Tn6003 changes to Tn6002 due to spontaneous excision in circular form of the erm(B)- and aphA3-containing macrolide-aminoglycoside-streptothricin (MAS) element.

Authors:  Claudio Palmieri; Marina Mingoia; Orietta Massidda; Eleonora Giovanetti; Pietro E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2012-08-13       Impact factor: 5.191

2.  Antibiotic-resistant invasive pneumococcal clones in Italy.

Authors:  Giovanni Gherardi; Loredana Fallico; Maria Del Grosso; Federica Bonanni; Fabio D'Ambrosio; Riccardo Manganelli; Giorgio Palù; Giordano Dicuonzo; Annalisa Pantosti
Journal:  J Clin Microbiol       Date:  2006-11-22       Impact factor: 5.948

Review 3.  Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.

Authors:  Françoise Van Bambeke; René R Reinert; Peter C Appelbaum; Paul M Tulkens; Willy E Peetermans
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Streptococcus pneumoniae pharyngeal colonization in school-age children and adolescents with cancer.

Authors:  Nicola Principi; Valentina Preti; Stefania Gaspari; Antonella Colombini; Marco Zecca; Leonardo Terranova; Maria Giuseppina Cefalo; Valentina Ierardi; Claudio Pelucchi; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

5.  Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age.

Authors:  Susanna Esposito; Alessandro Lizioli; Annalisa Lastrico; Enrica Begliatti; Alessandro Rognoni; Claudia Tagliabue; Laura Cesati; Vittorio Carreri; Nicola Principi
Journal:  Respir Res       Date:  2007-02-21

6.  The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.

Authors:  Josef Yayan
Journal:  Drug Des Devel Ther       Date:  2014-10-03       Impact factor: 4.162

7.  Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.

Authors:  Stephen G Jenkins; Steven D Brown; David J Farrell
Journal:  Ann Clin Microbiol Antimicrob       Date:  2008-01-11       Impact factor: 3.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.